
Delhi govt sets up committee to fast-track Covid-19 compensation
New Delhi: Delhi govt has formed a
group of ministers
(GOM) to expedite and examine the compensation process for families who lost loved ones during the Covid-19 pandemic. A senior official said on Wednesday that the committee will address pending claims and identify families still awaiting financial assistance.
Chief minister Rekha Gupta
had earlier stated that many bereaved families did not receive the compensation promised during the pandemic. "To address this, a special committee has been formed to identify such cases and provide financial support," she said.
The senior official said that the GOM is expected to meet in early June. Officials from the revenue, health, and other departments will present individual cases to the committee, which will then analyse the details and decide on the compensation disbursement.
Speaking in the Delhi Assembly earlier this year, the chief minister claimed that only 97 families had received financial assistance from the previous AAP-led administration. Official data shows that over 26,700 people in Delhi died due to Covid-related complications.
In 2021, the then-AAP govt launched the
Mukhyamantri Covid-19 Pariwar Aarthik Sahayata Yojana
, promising Rs 50,000 as ex gratia to the next of kin of every Covid victim, along with an additional Rs 2,500 monthly support if the deceased was the sole breadwinner of the family.
Families were also eligible for a one-time Rs 50,000 ex gratia from the
Delhi Disaster Response Fund
(DDRF).
Meanwhile, the capital has recorded two more Covid-related deaths in the past 48 hours, raising this year's toll to three. Delhi has logged 81 new infections since Friday, and the current active caseload stands at 375. "Nineteen patients are currently admitted to hospitals, while others are recovering at home," said Gupta, adding, "There's no reason for the public to panic. The govt is fully prepared."
New Delhi: Delhi govt has formed a group of ministers (GOM) to expedite and examine the compensation process for families who lost loved ones during the Covid-19 pandemic. A senior official said on Wednesday that the committee will address pending claims and identify families still awaiting financial assistance.
Chief minister Rekha Gupta had earlier stated that many bereaved families did not receive the compensation promised during the pandemic. "To address this, a special committee has been formed to identify such cases and provide financial support," she said.
The senior official said that the GOM is expected to meet in early June. Officials from the revenue, health, and other departments will present individual cases to the committee, which will then analyse the details and decide on the compensation disbursement.
Speaking in the Delhi Assembly earlier this year, the chief minister claimed that only 97 families had received financial assistance from the previous AAP-led administration. Official data shows that over 26,700 people in Delhi died due to Covid-related complications.
In 2021, the then-AAP govt launched the Mukhyamantri Covid-19 Pariwar Aarthik Sahayata Yojana, promising Rs 50,000 as ex gratia to the next of kin of every Covid victim, along with an additional Rs 2,500 monthly support if the deceased was the sole breadwinner of the family.
Families were also eligible for a one-time Rs 50,000 ex gratia from the Delhi Disaster Response Fund (DDRF).
Meanwhile, the capital has recorded two more Covid-related deaths in the past 48 hours, raising this year's toll to three. Delhi has logged 81 new infections since Friday, and the current active caseload stands at 375. "Nineteen patients are currently admitted to hospitals, while others are recovering at home," said Gupta, adding, "There's no reason for the public to panic. The govt is fully prepared."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


NDTV
18 minutes ago
- NDTV
US Researchers Develop New mRNA Vaccine To Fight Covid-19
New Delhi: Amid fresh surge in Covid-19 cases, a team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 and H5N1. While the currently available mRNA vaccines are highly effective at inducing an immune response against Covid, they present challenges like the high amount of mRNA needed to produce them and the constantly evolving nature of the pathogen. "The virus changes, moving the goal post, and updating the vaccine takes some time," said senior author Suresh Kuchipudi, chair of Infectious Diseases and Microbiology at the University of Pittsburgh School of Public Health. To address these challenges, the researchers created a proof-of-concept Covid vaccine using what's known as a "trans-amplifying" mRNA platform. In this approach, the mRNA is separated into two fragments -- the antigen sequence and the replicase sequence -- the latter of which can be produced in advance, saving crucial time in the event a new vaccine must be developed urgently and produced at scale. In addition, the researchers analysed the spike-protein sequences of all known variants of the SARS-CoV-2 for commonalities, rendering what's known as a "consensus spike protein" as the basis for the vaccine's antigen. In mice, the vaccine induced a robust immune response against many strains of SARS-CoV-2. "This has the potential for more lasting immunity that would not require updating, because the vaccine has the potential to provide broad protection," said Kuchipudi. "Additionally, this format requires an mRNA dose 40 times less than conventional vaccines, so this new approach significantly reduces the overall cost of the vaccine." The study, published in the journal npj Vaccines could inform more efficient vaccine development for other constantly evolving RNA viruses with pandemic potential, Kuchipudi said. "We hope to apply the principles of this lower-cost, broad-protection antigen design to pressing challenges like bird flu."


Business Standard
25 minutes ago
- Business Standard
Sansera secures long term contract from Airbus Defence and Space
Sansera Engineering has entered a long-term contract of value approx. Rs 160 crore (USD 18.80 million) with Airbus Defence and Space for the manufacture, supply, and support of the Airborne Intensive Care Transport Module (ICTM) for light and medium transport aircraft programs. The ICTM is an advanced airborne medical evacuation system designed to transport patients with varying levels of medical criticality, including those requiring intensive care, during emergencies and health crises. For the first time, Airbus has selected Sansera, an Indian supplier for the manufacturing of the ICTM Kit. Under this contract, Sansera will be responsible for the precision machining and structural assembly of the ICTM units.


Business Standard
25 minutes ago
- Business Standard
Aayush Wellness Limited Stock Price at 52 week High of Rs. 139.65 per share with good volumes
VMPL New Delhi [India], June 3: Aayush Wellness Limited [BSE:539528], India's preventive healthcare company has reported excellent results for the Financial year 2024-25 ended 31st March 2025. Company has reported income from operations of Rs. 73.34 crore for FY2024-25, multifold growth as compared to the income from operations of Rs. 60 lakh in the corresponding period last year. Net profit of the company for the FY 2024-25 was reported at Rs. 3.05 crore, 434% rise Y-o-Y as compared to the net profit of Rs. 57 lakh in the corresponding period in FY 2023-24. The stock price was up and touched 52 week high of Rs. 139.65 per share on 3 June 2025. The share price was in the buyer circuit for the last many days with good volumes. For Q4 FY2024-25, company reported net profit of Rs. 79 lakh, 368% growth Y-o-Y as compared to the net profit of Rs. 16.85 lakh in the Q4 FY 2023-24. Income from operations during the fourth quarter ended March 2025 was reported at Rs. 22.35 crore. -Income from Operations jump multifold to Rs. 73.34 crore in FY 2024-25 -Net Profit for FY 25 was reported at Rs. 3.05 crore, 434% rise Y-o-Y -Company is planning expansion into preventive healthcare with Smart Health Kiosks & Medical Support centre; To Invest upto Rs. 25 crore in the expansion -Company has rewarded its shareholders with a bonus issue and 1:10 stock split -Opens first centre in Mumbai, Aims to expand presence across India and to improve offline distribution network Mr. Naveena Kumar, Managing Director of Aayush Wellness Limited said "We feel proud to inform all our stakeholders that the company has demonstrated remarkable consistency in its growth trajectory, achieving significant milestones year after year and is progressing well on its long-term growth roadmap. Company has reported excellent numbers for FY 2025 with highest Revenue, EBITDA and Net Profit reported on a yearly basis. Company is growing strength to strength, delivering robust operational and financial performance maintaining healthy growth in revenue, margins and profitability. We expect the growth momentum to continue and expect to get further boost in coming years." In its effort to enhance shareholder value, the company executed a 1:10 stock split in August 2024, reducing the face value of each share from Rs10 to Rs1. This was followed by a 1:2 bonus issue in December 2024, further improving liquidity and widening investor interest. Aayush Wellness is also taking ambitious strides into offline preventive healthcare. Company has launched its first healthcare centre in Virar (Mumbai), Maharashtra. Inspired by the E Sanjeevani National Telemedicine Service of the Ministry of Health and Family Welfare, Aayush Wellness has installed a health ATM that shall conduct a wide range of diagnostics tests, in 2-3 minutes, maintain digital health records, and also facilitate Telemedicine to address health deficiencies before they become critical. The Company plans to invest up to Rs. 25 crores in the first phase and shall review further investments based on business requirements. This expansion will increase company's physical presence across geographies all over India, improve the offline distribution network for our products and provide complete preventive healthcare solutions under one roof. The company envisions a future where preventive healthcare becomes a cornerstone of everyday life, reducing dependency on reactive treatments. With this initiative, Aayush Wellness Limited continues to strengthen its presence in the $372 billion Indian healthcare market, offering solutions that cater to the evolving needs of consumers. The Cloud Clinic model through this Health ATM is unique as it will deliver affordable yet high quality healthcare services to under privileged population of India. Solution offer by the company not only promotes early detection and prevention but also empowers individuals, especially those in rural and semi-urban areas, to take charge of their health in an accessible, cost-effective manner." The health ATM shall be able to conduct a up to 59 test including blood test, sugar test, Urine test, Haemoglobin test, skin test, eye test, cancer risk test, Lipid Profile test, and other basic health checkups, at a very affordable price. Further, the health ATM shall also facilitate Telemedicine, maintain Digital Health Records, Cloud connectivity generates smart reports and integration with Ayushman Bharat Digital Mission to benefit majority of the Indian Population." With a mission to make preventive healthcare accessible, it addresses key sectors like tobacco deaddiction, nutrition, and healthcare enhancements--especially in underserved regions. Its herbal pan masala targets India's vast Rs44,000 Cr pan masala market, while nutritional and fortified food markets, valued at $2.5B and $1.5B respectively, offer strong growth potential. Flagship products include Dreamy Sleep Gummies, Beauty Bio Gummies, and Aayush Herbal Pan Masala. The stock closed at Rs129 on May 28, 2025, reflecting a growth of nearly 100% in the past three months, Over 600% in one year, and an astounding 6000% in two years. With these stellar returns, Aayush Wellness has firmly positioned itself as one of the top wealth creators on Dalal Street. About Aayush Wellness Limited: (ISO 9000 and 22000 certified company) Aayush Wellness Limited [BSE scrip code: 539528], established in 1989 is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation. We are India's preventive healthcare company committed to offer quality products and services to enhance the consumer well-being. Aayush Wellness continues to lead the industry in promoting healthier lifestyle choices through its diverse range of wellness products and services. For more information, please visit